Literature DB >> 26658224

Design and Interpretation of Human Sulfotransferase 1A1 Assays.

Ting Wang1, Ian Cook1, Thomas S Leyh2.   

Abstract

The human sulfotransferases (SULTs) regulate the activities of hundreds, if not thousands, of small molecule metabolites via transfer of the sulfuryl-moiety (-SO3) from the nucleotide donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the hydroxyls and amines of the recipients. Our understanding of the molecular basis of SULT catalysis has expanded considerably in recent years. The basic kinetic mechanism of these enzymes, previously thought to be ordered, has been redefined as random for SULT2A1, a representative member of the superfamily. An active-site cap whose structure and dynamics are highly responsive to nucleotides was discovered and shown to be critical in determining SULT selectivity, a topic of longstanding interest to the field. We now realize that a given SULT can operate in two specificity modes-broad and narrow-depending on the disposition of the cap. More recent work has revealed that the caps of the SULT1A1 are controlled by homotropic allosteric interactions between PAPS molecules bound at the dimer's active sites. These interactions cause the catalytic efficiency of SULT1A1 to vary in a substrate-dependent fashion by as much as two orders of magnitude over a range of PAPS concentrations that spans those found in human tissues. SULT catalysis is further complicated by the fact that these enzymes are frequently inhibited by their substrates. This review provides an overview of the mechanistic features of SULT1A1 that are important for the design and interpretation of SULT1A1 assays.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26658224      PMCID: PMC4810762          DOI: 10.1124/dmd.115.068205

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  35 in total

Review 1.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

2.  Tissue distribution and ontogeny of sulfotransferase enzymes in mice.

Authors:  Yazen Alnouti; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2006-06-28       Impact factor: 4.849

3.  Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins.

Authors:  Li Li; Charles N Falany
Journal:  J Cyst Fibros       Date:  2006-06-23       Impact factor: 5.482

4.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

5.  Xenobiotic metabolism in Parkinson's disease.

Authors:  G B Steventon; M T Heafield; R H Waring; A C Williams
Journal:  Neurology       Date:  1989-07       Impact factor: 9.910

6.  Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.

Authors:  J L Falany; C N Falany
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

7.  Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1.

Authors:  Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2010-12-01

8.  On the mechanism of aryl sulfotransferase.

Authors:  M W Duffel; W B Jakoby
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

9.  Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation.

Authors:  Josie L Falany; Nancy Macrina; Charles N Falany
Journal:  Breast Cancer Res Treat       Date:  2002-07       Impact factor: 4.872

10.  Identification and characterization of two amino acids critical for the substrate inhibition of human dehydroepiandrosterone sulfotransferase (SULT2A1).

Authors:  Lu-Yi Lu; Yin-Cheng Hsieh; Ming-Yih Liu; Yih-Hung Lin; Chun-Jung Chen; Yuh-Shyong Yang
Journal:  Mol Pharmacol       Date:  2007-11-27       Impact factor: 4.436

View more
  9 in total

1.  Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Isoform-specific therapeutic control of sulfonation in humans.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Biochem Pharmacol       Date:  2018-11-10       Impact factor: 5.858

3.  The NSAID allosteric site of human cytosolic sulfotransferases.

Authors:  Ting Wang; Ian Cook; Thomas S Leyh
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

4.  Allosteres to regulate neurotransmitter sulfonation.

Authors:  Kristie Darrah; Ting Wang; Ian Cook; Mary Cacace; Alexander Deiters; Thomas S Leyh
Journal:  J Biol Chem       Date:  2018-12-13       Impact factor: 5.157

5.  The structure of the catechin-binding site of human sulfotransferase 1A1.

Authors:  Ian Cook; Ting Wang; Mark Girvin; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-23       Impact factor: 11.205

6.  Enzyme Kinetics of PAPS-Sulfotransferase.

Authors:  Margaret O James
Journal:  Methods Mol Biol       Date:  2021

7.  The Human UGT2B7 Nanodisc.

Authors:  Ian Cook; Anna B Asenjo; Hernando Sosa; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2019-12-31       Impact factor: 3.922

8.  Combinatorial Biosynthesis of Sulfated Benzenediol Lactones with a Phenolic Sulfotransferase from Fusarium graminearum PH-1.

Authors:  Linan Xie; Dongliang Xiao; Xiaojing Wang; Chen Wang; Jing Bai; Qun Yue; Haitao Yue; Ye Li; István Molnár; Yuquan Xu; Liwen Zhang
Journal:  mSphere       Date:  2020-11-25       Impact factor: 4.389

9.  Insights into the substrate binding mechanism of SULT1A1 through molecular dynamics with excited normal modes simulations.

Authors:  Balint Dudas; Daniel Toth; David Perahia; Arnaud B Nicot; Erika Balog; Maria A Miteva
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.